sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate

C25H34N11NaO5S3 — CID 173412470

IUPACsodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate
SMILESC=CCN1CCN(CCCn2nnnc2SCC2(C(=O)[O-])CS[C@@H]3C(NC(=O)C(=NOC)c4csc(N)n4)C(=O)N3C2)CC1.[Na+]
InChIInChI=1S/C25H35N11O5S3.Na/c1-3-5-33-8-10-34(11-9-33)6-4-7-36-24(29-31-32-36)44-15-25(22(39)40)13-35-20(38)18(21(35)43-14-25)28-19(37)17(30-41-2)16-12-42-23(26)27-16;/h3,12,18,21H,1,4-11,13-15H2,2H3,(H2,26,27)(H,28,37)(H,39,40);/q;+1/p-1/t18?,21-,25?;/m1./s1
InChIKeyBHQPVZCLUVBABH-DFCMHPFJSA-M
MW687.81 g/mol
LogP-4.81
Rot. Bonds14

About sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate

sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate (PubChem CID 173412470) has the molecular formula C25H34N11NaO5S3 and a molecular weight of 687.81 g/mol. Its IUPAC name is sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate.

Molecular Properties

Compound Namesodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate
PubChem CID173412470
Molecular FormulaC25H34N11NaO5S3
Molecular Weight687.81 g/mol
Exact Mass687.18
IUPAC Namesodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate
SMILESC=CCN1CCN(CCCn2nnnc2SCC2(C(=O)[O-])CS[C@@H]3C(NC(=O)C(=NOC)c4csc(N)n4)C(=O)N3C2)CC1.[Na+]
InChIInChI=1S/C25H35N11O5S3.Na/c1-3-5-33-8-10-34(11-9-33)6-4-7-36-24(29-31-32-36)44-15-25(22(39)40)13-35-20(38)18(21(35)43-14-25)28-19(37)17(30-41-2)16-12-42-23(26)27-16;/h3,12,18,21H,1,4-11,13-15H2,2H3,(H2,26,27)(H,28,37)(H,39,40);/q;+1/p-1/t18?,21-,25?;/m1./s1
InChIKeyBHQPVZCLUVBABH-DFCMHPFJSA-M
XLogP-4.81
TPSA200.12 Ų
H-Bond Donors2
H-Bond Acceptors17
Rotatable Bonds14
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500687.81
LogP ≤ 5-4.81
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate?
The IUPAC name of sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate (CID 173412470) is sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate.
What is the SMILES notation for sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate?
The canonical SMILES for sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate is C=CCN1CCN(CCCn2nnnc2SCC2(C(=O)[O-])CS[C@@H]3C(NC(=O)C(=NOC)c4csc(N)n4)C(=O)N3C2)CC1.[Na+].
What is the InChIKey of sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate?
The InChIKey is BHQPVZCLUVBABH-DFCMHPFJSA-M. The full InChI is InChI=1S/C25H35N11O5S3.Na/c1-3-5-33-8-10-34(11-9-33)6-4-7-36-24(29-31-32-36)44-15-25(22(39)40)13-35-20(38)18(21(35)43-14-25)28-19(37)17(30-41-2)16-12-42-23(26)27-16;/h3,12,18,21H,1,4-11,13-15H2,2H3,(H2,26,27)(H,28,37)(H,39,40);/q;+1/p-1/t18?,21-,25?;/m1./s1.
What are the key properties of sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate?
sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate has a molecular weight of 687.81 g/mol, XLogP of -4.81, 14 rotatable bonds, 2 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for sodium (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1-[3-(4-prop-2-enylpiperazin-1-yl)propyl]tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]octane-3-carboxylate is sourced from PubChem (CID 173412470), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).